Latest Biotech News

Ginkgo Bioworks, Inductive Bio, and Tangible Scientific have partnered to create an integrated AI-driven lab-in-the-loop platform aimed at streamlining drug discovery workflows. This collaboration...

Multiple groundbreaking studies have advanced understanding and treatment options across cancer types. Amgen presented AMG-410, a pan-KRAS inhibitor targeting diverse KRAS mutations prevalent in...

Researchers have introduced cutting-edge imaging and quantum control methodologies with broad impact. Nanjing University scientists developed a dual-frequency angular-multiplexed fringe projection...

The FDA has issued multiple notable regulatory decisions impacting the biotech sector. This includes lifting the clinical hold on Rocket Pharmaceuticals’ gene therapy trial for Danon disease with...

Recent studies have made significant strides in cancer diagnostics and prognostication. Natera’s Signatera circulating tumor DNA test successfully predicted improved disease-free and overall...

Rocket Pharmaceuticals has received approval from the FDA to resume its Phase 2 gene therapy trial testing RP-A501 for Danon disease following a clinical hold. The hold was issued due to a patient...

Viking Therapeutics has reported mid-stage Phase 2 results for its oral weight loss drug VK-2735, demonstrating up to 12.2% mean weight reduction after 13 weeks. However, significant...

Researchers at UC San Diego’s Sanford Stem Cell Institute have developed Graphene-Mediated Optical Stimulation (GraMOS), a novel non-genetic technique to accelerate the maturation of human brain...

Natera announced statistically significant improvements in disease-free and overall survival for Signatera-positive muscle-invasive bladder cancer patients treated with Genentech's Tecentriq in...

VantAI, a generative AI and protein interaction design company, entered a collaboration with Halda Therapeutics valued over $1 billion to develop novel selective proximity-based therapies across...

Australian pharmaceutical company CSL revealed a major restructuring plan involving spinning off its influenza vaccine business, Seqirus, into a standalone company and cutting up to 15% of its...

The FDA issued a complete response letter for PTC Therapeutics’ 15-lipoxygenase inhibitor, vatiquinone, declining approval for Friedreich’s ataxia due to insufficient evidence of efficacy. Despite...

Dutch researchers published a groundbreaking study in Radiology demonstrating that a hybrid reading strategy combining artificial intelligence with radiologist assessment improves mammogram...

Stanford University researchers have developed an innovative spray drying formulation platform enabling the conversion of traditionally intravenous protein therapeutics into stable,...

Neuroscientist Laura Lewis and colleagues at MIT have visualized, using real-time imaging, pulsatile cerebrospinal fluid flow in the brain’s glymphatic system that clears toxic waste products such...

Researchers at UC San Diego have developed Graphene-Mediated Optical Stimulation (GraMOS), a novel non-genetic method that uses graphene to convert light into electrical cues, accelerating the...

Xoma Royalty, a drug royalty specialist, has acquired struggling biotech Mural Oncology for approximately $36 million, marking its fourth acquisition since June 2025. This move continues Xoma’s...

The FDA has lifted a clinical hold on Rocket Pharmaceuticals' pivotal Phase II trial for the gene therapy RP-A501 targeting Danon disease, after implementing protocol adjustments including dose...

Stanford University researchers have developed a spray drying technique incorporating a glassy surfactant excipient (MoNi) to convert intravenous protein-based therapeutics into high-concentration...

A comprehensive study published in Nature Communications elucidates the molecular and clinical features of pulmonary large cell neuroendocrine carcinoma (LCNEC), a rare and aggressive lung cancer...